Search

everythinglearnresearchcommunity

for

Search:↓

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Consider benefits and risks of new alopecia treatments for safety.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Sertraline can cause hair loss, which stops after stopping the drug.

Different types of diffuse alopecia affect mental health differently, requiring personalized treatment.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Effective symptom management in IBD improves quality of life and prevents complications.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

More severe alopecia areata can lower quality of life.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Skin and hair can regenerate after injury due to changes in gene activity, with potential links to how cancer spreads. Future research should focus on how new hair follicles form and the processes that trigger their creation.

miR-140-5p in certain cell vesicles helps hair growth by boosting cell proliferation.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

People with alopecia areata face challenges but find ways to cope and live fulfilling lives.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.